rs3212756
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000215.4(JAK3):c.1786+91C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0124 in 836,798 control chromosomes in the GnomAD database, including 728 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.045 ( 481 hom., cov: 30)
Exomes 𝑓: 0.0055 ( 247 hom. )
Consequence
JAK3
NM_000215.4 intron
NM_000215.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.00
Publications
4 publications found
Genes affected
JAK3 (HGNC:6193): (Janus kinase 3) The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008]
JAK3 Gene-Disease associations (from GenCC):
- T-B+ severe combined immunodeficiency due to JAK3 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 19-17837038-G-T is Benign according to our data. Variant chr19-17837038-G-T is described in ClinVar as Benign. ClinVar VariationId is 1281410.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.152 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| JAK3 | NM_000215.4 | c.1786+91C>A | intron_variant | Intron 13 of 23 | ENST00000458235.7 | NP_000206.2 | ||
| JAK3 | NM_001440439.1 | c.1786+91C>A | intron_variant | Intron 13 of 23 | NP_001427368.1 | |||
| JAK3 | XM_011527991.3 | c.1787-84C>A | intron_variant | Intron 13 of 13 | XP_011526293.2 | |||
| JAK3 | XR_007066796.1 | n.1836+91C>A | intron_variant | Intron 13 of 19 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0452 AC: 6498AN: 143734Hom.: 476 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
6498
AN:
143734
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00905 AC: 1246AN: 137606 AF XY: 0.00686 show subpopulations
GnomAD2 exomes
AF:
AC:
1246
AN:
137606
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00552 AC: 3825AN: 692956Hom.: 247 Cov.: 10 AF XY: 0.00443 AC XY: 1616AN XY: 364692 show subpopulations
GnomAD4 exome
AF:
AC:
3825
AN:
692956
Hom.:
Cov.:
10
AF XY:
AC XY:
1616
AN XY:
364692
show subpopulations
African (AFR)
AF:
AC:
2866
AN:
17962
American (AMR)
AF:
AC:
335
AN:
33714
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19556
East Asian (EAS)
AF:
AC:
0
AN:
29432
South Asian (SAS)
AF:
AC:
22
AN:
65594
European-Finnish (FIN)
AF:
AC:
1
AN:
39938
Middle Eastern (MID)
AF:
AC:
17
AN:
2602
European-Non Finnish (NFE)
AF:
AC:
165
AN:
450688
Other (OTH)
AF:
AC:
419
AN:
33470
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
184
369
553
738
922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0453 AC: 6520AN: 143842Hom.: 481 Cov.: 30 AF XY: 0.0441 AC XY: 3069AN XY: 69524 show subpopulations
GnomAD4 genome
AF:
AC:
6520
AN:
143842
Hom.:
Cov.:
30
AF XY:
AC XY:
3069
AN XY:
69524
show subpopulations
African (AFR)
AF:
AC:
6148
AN:
39500
American (AMR)
AF:
AC:
267
AN:
13690
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3410
East Asian (EAS)
AF:
AC:
0
AN:
4564
South Asian (SAS)
AF:
AC:
2
AN:
4308
European-Finnish (FIN)
AF:
AC:
0
AN:
8906
Middle Eastern (MID)
AF:
AC:
3
AN:
284
European-Non Finnish (NFE)
AF:
AC:
30
AN:
66280
Other (OTH)
AF:
AC:
70
AN:
2018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
252
504
755
1007
1259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
35
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.